Health Service Executive

Dáil Éireann Debate, Tuesday - 7 July 2026

• Díospóireachtaí
• Aimsigh díospóireacht
  • Díospóireachtaí na Dála
  • Díospóireachtaí an tSeanaid
  • Díospóireachtaí Coiste
• Aimsigh vótáil
  • Vótálacha na Dála
  • Vótálacha an tSeanaid
  • Vótálacha Coiste
• Ceisteanna Parlaiminte
  • Ceisteanna scríofa
  • Ceisteanna ó bhéal
• Leideanna cuardaigh
• Nuair a bhíonn tionchar tromchúiseach ag aithrisí

Tuesday, 7 July 2026

Ceisteanna (873)

Pádraig O'Sullivan

Ceist:

873. Deputy Pádraig O'Sullivan asked the Minister for Health the number of medicines for rare diseases or orphan conditions for which an application for reimbursement has been received by the Health Service Executive in each of the years 2021 to date in 2026; the number approved; the number refused, in tabular form; and if she will make a statement on the matter. [51878/26]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• An Freagra Roimhe Sin
• An Chéad Fhreagra eile